Skip to main content
PLSE logo

PLSE · Pulse Biosciences, Inc.

$35.17 -0.30 (-0.85%)
Market Cap
$2.45B
Shares
69.21M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Paul LaViolette $7,427,899
Jon Skinner $2,843,000
Darrin R. Uecker $869,889
Kevin P. Danahy $854,577
Mitchell E. Levinson
Burke T. Barrett
Fiscal 2024
Executive Total
Burke T. Barrett $8,435,605
Darrin R. Uecker $616,410
Kevin P. Danahy $616,410
Paul LaViolette
Jon Skinner
Mitchell E. Levinson
Fiscal 2023
Executive Total
Kevin P. Danahy $5,864,450
Darrin R. Uecker $5,390,028
Mitchell E. Levinson $1,694,562
Paul LaViolette
Jon Skinner
Burke T. Barrett
Fiscal 2022
Executive Total
Kevin P. Danahy $2,263,256
Darrin R. Uecker $487,235
Mitchell E. Levinson $361,338
Jon Skinner
Paul LaViolette
Burke T. Barrett
Fiscal 2021
Executive Total
Darrin R. Uecker $2,286,036
Mitchell E. Levinson $1,062,416
Kevin P. Danahy

Executive changes

Person Change Filed
Liane R. Teplitsky Appointed 2026-04-09
Kevin P. Danahy Resigned 2026-02-27
Key facts CIK 1625101 CUSIP 74587B101 13F (30d) 13 filings 13 filers Visit website Investor relations